This review sturdily backs the oncogenic probable of LSD1 in different tumors, indicating that LSD1 levels can be used to monitor and identify different tumors and can be a useful biomarker of progression and fair diagnosis in different tumor patients. The gene discussed is KDM1A; the disease is neoplasm.